Our team’s preliminary work has previously reported a linear pathway where ZFHX4-AS1 upregulates its neighboring gene ZFHX4, which in turn promotes the expression of SOX2, thereby accelerating glioma progression (23). This evidence concerns the gene SOX2 and central nervous system cancer.